Surgery Websites
Thoracic Oncology Program »  Meet the Team »  Radiation Oncologists »  Steve Braunstein, M.D., Ph.D.
Steve Braunstein, M.D., Ph.D.

Steve Braunstein, M.D., Ph.D.

Assistant Professor
Department of Radiation Oncology

Open Popup
  • 1987-91, Rice University, Houston, TX,  B.A.  French
  • 1993-02, University of Pennsylvania, Ph.D. English
  • 1995-02, University of Pennsylvania, M.D., Medicine
  • 2002-2003 M.D. Anderson Cancer Center, Intern, Medicine/Surgery
  • 2003-2007 M.D. Anderson Cancer Center, Resident, Radiation Oncology 
  • American Board of Radiology
  • Thoracic Oncology Program
  • Head and Neck Oncology Program
  • Visible Tumor and High-Risk Skin Cancer Program
  • Department of Radiation Oncology
  • Brachytherapy
  • Bronchioloalveolar Carcinoma (BAC)
  • Chemoradiation
  • CyberKnife irradiation for lung and skull base
  • Electron beam and orthovoltage irradiation
  • External-beam radiation therapy
  • Head & Neck Cancer
  • Hyperthemia
  • Intensity-modulated radiation therapy
  • Non-Small Cell Lung Cancer
  • Small-Cell Lung Cancer
  • Advanced imaging and radiation planning
  • Head and neck and lung cancers
  • Image-guided and adaptive radiation therapy
  • Outcomes and quality of life
  • Radiation in combination with chemotherapy and targeted agents
  • Radiation sensitizers and protectors

In lung cancer, Dr. Yom has conducted research quantifying the risks of pneumonitis and esophagitis when chemotherapy and radiation are given simultaneously. Her research findings were important in establishing the early use of intensity-modulated radiation therapy for lung cancer in combination with 4-dimensional CT-based planning. She has particular expertise in the delivery of chemoradiation therapy for advanced-stage lung cancer, and also the delivery of non-invasive stereotactic CyberKnife radiation for early-stage lung cancer. Her hope is that better understanding of radiation toxicities will permit higher treatment doses, increase the rate of cure and improve patient quality of life. She is strongly committed to research that will lead to more effective, less toxic, and more highly individualized therapy for patients.

Dr. Yom is an investigator on many research studies in head and neck and lung cancer at UCSF, including trials related to to image-guided radiation, head and neck patients' quality of life, and combinations of novel systemic agents with radiation therapy. She is especially interested in improved clinical and translational prognostic models in order to provide more effective and individualized therapy. It is hoped that the reduction of toxicities, both through technical and biologic means, will improve patients' quality of life and potentially enable physicians to deliver more intelligently targeted radiation and chemotherapy doses in search of a better chance of cure. She believes in multidisciplinary management and a unified, team-oriented approach to patient care

 

Site Directory
    X